Stockscreener 앱 받기
21.22
1.12%
-0.24
시간 외 거래:
21.20
-0.02
-0.09%
전일 마감가:
$21.46
열려 있는:
$22.25
하루 거래량:
66,517
Relative Volume:
0.34
시가총액:
$302.64M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.57%
1개월 성능:
+4.64%
6개월 성능:
+3.71%
1년 성능:
-41.94%
1일 변동 폭
$21.00
$22.25
1주일 범위
$20.64
$22.25
52주 변동 폭
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
명칭
Neurogene Inc
전화
(877) 237-5020
주소
535 W 24TH STREET, NEW YORK
NGNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
21.22 | 303.64M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Craig Hallum | Buy |
| 2025-05-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2024-03-21 | 개시 | William Blair | Outperform |
| 2024-01-08 | 개시 | H.C. Wainwright | Buy |
| 2024-01-05 | 개시 | Stifel | Buy |
| 2024-01-04 | 개시 | TD Cowen | Outperform |
모두보기
Neurogene Inc 주식(NGNE)의 최신 뉴스
Price momentum metrics for Neurogene Inc. explainedAlpha Generation Strategy with Low Volatility - Newser
Will Neurogene Inc. bounce back from current supportAI Model Forecasting Reversal and Breakout Zones - Newser
What makes Neurogene Inc. stock price move sharplyDaily Exit and Entry Price Prediction - Newser
What risks could impact Neurogene Inc. stock performanceTechnical Chart Summary for Momentum Stocks - Newser
How to monitor Neurogene Inc. with trend dashboardsFree Buy Signal Based on Chart Analysis - Newser
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Can trapped investors hope for a rebound in Neurogene Inc.Free Entry Zone Strategy for Consistent Profit - Newser
Using data models to predict Neurogene Inc. stock movementNeural Model for Stock Price Movement - Newser
Visual analytics tools that track Neurogene Inc. performanceFree Risk Controlled Short Term Trade Plans - Newser
Neurogene Inc. Moves Into Bullish Territory Based on MACDFast Gaining Stock Screener Reports Released - metal.it
What is the risk reward ratio of investing in Neurogene Inc. stockFree Bull & Bear Market Updates - Jammu Links News
Is Neurogene Inc. stock overvalued or undervaluedUnlock powerful stock screening tools today - Jammu Links News
What drives Neurogene Inc. stock priceUnlock powerful market trend analysis - Jammu Links News
How strong is Neurogene Inc. company’s balance sheetTrack high-yield stocks before they peak - Jammu Links News
How volatile is Neurogene Inc. stock compared to the marketUnlock daily trading alerts for profits - Jammu Links News
What are Neurogene Inc. company’s key revenue driversBuild your wealth with consistent stock growth - Jammu Links News
What analysts say about Neurogene Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
Is it the right time to buy Neurogene Inc. stockFree Stock Market Trend Analysis - Jammu Links News
What are analysts’ price targets for Neurogene Inc. in the next 12 monthsMaximize portfolio growth with strategic plans - Jammu Links News
What markets is DRTSW expanding into Is Neurogene Inc. stock a good long term investment optionAchieve breakthrough profits with smart strategies - Jammu Links News
What are the latest earnings results for Neurogene Inc.Identify undervalued stocks poised to rally - Jammu Links News
Neurogene Inc. stock retracement – recovery analysisSmart Trend Analysis With Buy Point Cues - Newser
Can machine learning forecast Neurogene Inc. recoveryFree Fast Gaining Stock Screener Report - Newser
Chart based analysis of Neurogene Inc. trendsIntraday Signal Forecast for Fast Traders - Newser
Neurogene Inc. stock trend outlook and recovery pathFree Chart Driven High Reward Trading Setup - Newser
Neurogene (NGNE) to Release Earnings on Friday - Defense World
Order flow analysis tools used on Neurogene Inc.Short-Term Price Breakout Signal Analysis - Newser
Ranking Neurogene Inc. among high performing stocks via toolsConsistent Profit Signals with AI Models - Newser
What institutional investors are buying Neurogene Inc. stockDaily Trading Review That Work - Jammu Links News
Analysts Set Neurogene Inc. (NASDAQ:NGNE) PT at $46.17 - Defense World
Is Neurogene Inc. reversing from oversold territoryDaily Profit Watch With Forecast Confidence - Newser
Neurogene Insiders Bolster Stock Holdings by $1.46m, Showing Optimism - AInvest
Screener Results Flag Neurogene Inc. as OversoldWatchlist for Smart Swing Trading Updated - metal.it
Why Neurogene Inc. stock attracts strong analyst attentionFree ROI Boosting Trade Opportunity Calendar - Newser
How Neurogene Inc. stock performs during market volatilityFree Access to Smart Investment Tips - Newser
Neurogene Inc (NGNE) 재무 분석
Neurogene Inc (NGNE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):